Mandrup-Poulsen, Thomas

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 1,798

A guiding map for inflammation

Netea, M. G., Balkwill, F., Chonchol, M., Cominelli, F., Donath, M. Y., Giamarellos-Bourboulis, E. J., Golenbock, D., Gresnigt, M. S., Heneka, M. T., Hoffman, H. M., et al. (2017) · Nature Immunology

Immune Response and InflammationInflammation biomarkers and pathways

Cited by 831

Inflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetes

Donath, M. Y., St�rling, J., Maedler, K., & Mandrup-Poulsen, T. (2003) · Journal of Molecular Medicine

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 422

Targeting innate immune mediators in type 1 and type 2 diabetes

Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology

Adipokines, Inflammation, and Metabolic DiseasesPancreatic function and diabetes

Cited by 416

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes

Larsen, C. M., Faulenbach, M., Vaag, A., Ehses, J. A., Donath, M. Y., & Mandrup-Poulsen, T. (2009) · Diabetes Care

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 401

An immune origin of type 2 diabetes?

Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 394

Poor pregnancy outcome in women with type 2 diabetes

Clausen, T. D., Mathiesen, E., Ekbom, P., Hellmuth, E., Mandrup-Poulsen, T., & Damm, P. (2005) · Diabetes Care

Gestational Diabetes Research and ManagementPregnancy and Medication Impact

Cited by 318

Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus

Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. (2011) · Molecular Medicine

Histone Deacetylase Inhibitors ResearchSirtuins and Resveratrol in Medicine

Cited by 261

Proliferation of sorted human and rat beta cells

Parnaud, G., Bosco, D., Berney, T., Pattou, F., Kerr-Conte, J., Donath, M. Y., Bruun, C., Mandrup-Poulsen, T., Billestrup, N., & Halban, P. A. (2007) · Diabetologia

Pancreatic function and diabetesDiabetes and associated disorders

Cited by 232

An Isochemogenic set of inhibitors to define the therapeutic potential of histone deacetylases in β-cell protection

Wagner, F. F., Lundh, M., Kaya, T., McCarren, P., Zhang, Y.-L., Chattopadhyay, S., Gale, J. P., Galbo, T., Fisher, S. L., Meier, B. C., et al. (2016) · ACS Chemical Biology

Histone Deacetylase Inhibitors ResearchEnzyme function and inhibition

Cited by 86

Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant

Qian, J., Stefanovski, D., Andersen, P. A. K., Vujovic, N., Kelly, L., Lepson, J., Nguyen, H., Byrne, S., Wang, W., Mandrup-Poulsen, T., et al. (2026) · Diabetes Care

Circadian rhythm and melatoninPancreatic function and diabetes

Cited by 0